Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

71.9K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.9K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

553
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
553
Tissue Transplantation01:24

Tissue Transplantation

448
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
448

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Management of Fulminant C. difficile Infection in an Immunocompromised Patient: Balancing Risk and Necessity.

Gastroenterology·2026
Same author

AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert Review.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

<i>Clostridioides difficile</i> Infection: Harmonizing Patient Care.

Gastro hep advances·2026
Same author

Beyond the 'one nucleus, one whole genome' rule.

Trends in genetics : TIG·2026
Same author

What's New and What's Next in Fecal Microbiota Transplantation?

Biologics : targets & therapy·2025
Same author

Influence of Social Support on Peri-Operative Pain: A Secondary Sub-Sample Analysis of a Prospective Observational Trial.

European journal of pain (London, England)·2025

Related Experiment Video

Updated: Aug 8, 2025

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.2K

Fecal Microbiota Transplantation.

Yao-Wen Cheng1, Monika Fischer2

  • 1Department of Gastroenterology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, California.

Clinics in Colon and Rectal Surgery
|February 27, 2023
PubMed
Summary
This summary is machine-generated.

Fecal microbiota transplantation (FMT) effectively treats recurrent C. difficile infection (CDI) with high cure rates. Emerging research also shows FMT benefits severe CDI and may help ulcerative colitis patients.

Keywords:
Clostridioides difficilecolectomycolitiscolonoscopyfecal microbiota transplantationtoxic megacolon

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K

Related Experiment Videos

Last Updated: Aug 8, 2025

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

4.2K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.9K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.2K

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • Fecal microbiota transplantation (FMT) involves transferring gut microbes from a healthy donor to a patient.
  • Current guidelines endorse FMT for multiply recurrent *Clostridioides difficile* infection (CDI) post-antibiotics, achieving ~90% cure rates.

Purpose of the Study:

  • To review the efficacy of FMT in managing recurrent and severe CDI.
  • To explore FMT's potential in treating ulcerative colitis and other conditions.

Main Methods:

  • Literature review of studies on FMT for CDI and ulcerative colitis.
  • Analysis of clinical outcomes, including cure rates, mortality, and colectomy rates.

Main Results:

  • FMT demonstrates high efficacy in preventing multiply recurrent CDI.
  • Emerging evidence supports FMT for severe/fulminant CDI, reducing mortality and colectomy rates.
  • FMT shows promise as salvage therapy for refractory CDI patients.

Conclusions:

  • FMT is a highly effective treatment for recurrent CDI and a valuable option for severe cases.
  • Early consideration of FMT in severe CDI is recommended.
  • FMT is a potential therapeutic strategy for ulcerative colitis and other microbiome-related disorders.